Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study
Crossref DOI link: https://doi.org/10.1136/bmjopen-2019-034585
Published Online: 2020-05-17
Published Print: 2020-05
Update policy: https://doi.org/10.1136/crossmarkpolicy
Wu, Zexuan
Wu, Dexi
Jiang, Jingzhou
Chen, Ailan
Zheng, Dong-Dan
Li, Jianhao
Dong, Yugang
Chen, Yili http://orcid.org/0000-0001-9999-9413
License valid from 2020-05-16